↓ Skip to main content

Case Report: Addition of PD-1 Antibody Camrelizumab Overcame Resistance to Trastuzumab Plus Chemotherapy in a HER2-Positive, Metastatic Gallbladder Cancer Patient

Overview of attention for article published in Frontiers in immunology, January 2022
Altmetric Badge

Mentioned by

twitter
2 X users

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
16 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Case Report: Addition of PD-1 Antibody Camrelizumab Overcame Resistance to Trastuzumab Plus Chemotherapy in a HER2-Positive, Metastatic Gallbladder Cancer Patient
Published in
Frontiers in immunology, January 2022
DOI 10.3389/fimmu.2021.784861
Pubmed ID
Authors

Li Wang, Xiaomo Li, Yurong Cheng, Jing Yang, Si Liu, Tonghui Ma, Li Luo, Yanping Hu, Yi Cai, Dong Yan

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 16 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 16 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 2 13%
Professor 1 6%
Student > Bachelor 1 6%
Student > Postgraduate 1 6%
Unknown 11 69%
Readers by discipline Count As %
Business, Management and Accounting 1 6%
Nursing and Health Professions 1 6%
Economics, Econometrics and Finance 1 6%
Social Sciences 1 6%
Medicine and Dentistry 1 6%
Other 0 0%
Unknown 11 69%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 January 2022.
All research outputs
#20,669,432
of 25,392,582 outputs
Outputs from Frontiers in immunology
#24,766
of 31,541 outputs
Outputs of similar age
#388,282
of 515,736 outputs
Outputs of similar age from Frontiers in immunology
#1,239
of 1,550 outputs
Altmetric has tracked 25,392,582 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 31,541 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.4. This one is in the 13th percentile – i.e., 13% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 515,736 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 14th percentile – i.e., 14% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 1,550 others from the same source and published within six weeks on either side of this one. This one is in the 13th percentile – i.e., 13% of its contemporaries scored the same or lower than it.